The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
暂无分享,去创建一个
M. T. Pellecchia | E. Tolosa | R. Freeman | W. Poewe | D. Berg | M. Stamelou | W. Meissner | G. Halliday | I. Litvan | R. Sakakibara | K. Seppi | G. Wenning | P. Cortelli | G. Calandra-Buonaura | I. Stankovic | P. Low | H. Kaufmann | J. Palma | F. Krismer | L. Vignatelli | G. Höglinger | N. Quinn | A. Fanciulli | H. Ling | J. Panicker | Y. Miki | A. Lang | S. Tsuji | Tom Warner | T. Warner | I. Stanković
[1] W. Poewe,et al. Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis , 2017, PloS one.
[2] Raj Nair,et al. Methods of formal consensus in classification/diagnostic criteria and guideline development. , 2011, Seminars in arthritis and rheumatism.
[3] M. Schulzer,et al. Early Clinical Features Differentiate Cerebellar Variant MSA and Sporadic Ataxia , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[4] K. Miszkiel,et al. “Hot cross bun” sign in a patient with parkinsonism secondary to presumed vasculitis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[5] Tove Faber Frandsen,et al. The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: a systematic review , 2018, Journal of the Medical Library Association : JMLA.
[6] B. Boeve,et al. Alpha-Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body Synucleinopathies. , 2020, Annals of neurology.
[7] N. Quinn,et al. A validation exercise on the new consensus criteria for multiple system atrophy , 2009, Movement disorders : official journal of the Movement Disorder Society.
[8] I Litvan,et al. Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.
[9] W. Poewe,et al. Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease , 2020, Movement disorders : official journal of the Movement Disorder Society.
[10] E. Tolosa,et al. REM sleep behavior disorder and vocal cord paralysis in Machado‐Joseph disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[11] R. Sakakibara,et al. Bladder dysfunction as the initial presentation of multiple system atrophy: a prospective cohort study , 2018, Clinical Autonomic Research.
[12] G K Wenning,et al. Sniffing the diagnosis: Olfactory testing in neurodegenerative parkinsonism. , 2017, Parkinsonism & related disorders.
[13] M. Yoshita,et al. Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy , 1998, Journal of the Neurological Sciences.
[14] S. Lorenzl,et al. Which ante mortem clinical features predict progressive supranuclear palsy pathology? , 2017, Movement disorders : official journal of the Movement Disorder Society.
[15] N. Quinn,et al. “Atypical” atypical parkinsonism: New genetic conditions presenting with features of progressive supranuclear palsy, corticobasal degeneration, or multiple system atrophy—A diagnostic guide , 2013, Movement disorders : official journal of the Movement Disorder Society.
[16] N. Quinn,et al. Multiple system atrophy--the nature of the beast. , 1989, Journal of neurology, neurosurgery, and psychiatry.
[17] P. Cortelli,et al. The natural history of idiopathic autonomic failure , 2018, Neurology.
[18] C. Soto,et al. Alpha‐Synuclein Oligomers and Neurofilament Light Chain Predict Phenoconversion of Pure Autonomic Failure , 2021, Annals of neurology.
[19] M. T. Pellecchia,et al. Stridor in multiple system atrophy , 2019, Neurology.
[20] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[21] R. Freeman,et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness , 2021, Clinical Autonomic Research.
[22] G. Chiro,et al. Computed tomography, magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in multiple system atrophy and pure autonomic failure , 1991, Clinical Autonomic Research.
[23] M. T. Pellecchia,et al. Can Autonomic Testing and Imaging Contribute to the Early Diagnosis of Multiple System Atrophy? A Systematic Review and Recommendations by the Movement Disorder Society Multiple System Atrophy Study Group , 2020, Movement disorders clinical practice.
[24] K. Ito,et al. A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. , 1995, Journal of the autonomic nervous system.
[25] Seung-June Oh,et al. Impaired detrusor contractility is the pathognomonic urodynamic finding of multiple system atrophy compared to idiopathic Parkinson's disease. , 2015, Parkinsonism & related disorders.
[26] N. Quinn,et al. Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.
[27] Irene Litvan,et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: a clinicopathological study , 1999, Journal of neurology, neurosurgery, and psychiatry.
[28] C. Adler,et al. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. , 2013, Sleep medicine.
[29] W. Poewe,et al. Cognitive impairment in multiple system atrophy: A position statement by the neuropsychology task force of the MDS multiple system atrophy (MODIMSA) study group , 2014, Movement disorders : official journal of the Movement Disorder Society.
[30] G. Treglia,et al. Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: A systematic review and a meta-analysis , 2011, Clinical Neurology and Neurosurgery.
[31] M. Schocke,et al. Significance of MRI in Diagnosis and Differential Diagnosis of Parkinson’s Disease , 2010, Neurodegenerative Diseases.
[32] D. Royall,et al. Meta‐analysis of 123I‐MIBG cardiac scintigraphy for the diagnosis of Lewy body–related disorders , 2011, Movement disorders : official journal of the Movement Disorder Society.
[33] N. Quinn,et al. Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study. , 2019, Brain : a journal of neurology.
[34] Gerta Rücker,et al. 18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment , 2017, The Journal of Nuclear Medicine.
[35] D. Gruber,et al. Laryngeal Movement Disorders in Multiple System Atrophy: A Diagnostic Biomarker? , 2020, Movement disorders : official journal of the Movement Disorder Society.
[36] R. Guy,et al. Scanning the horizon: a systematic literature review of methodologies , 2019, BMJ Open.
[37] S. Orimo,et al. 123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis. , 2012, Parkinsonism & related disorders.
[38] G. Ebersbach,et al. Sonographic assessment of urinary retention in multiple system atrophy and idiopathic Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[39] W. Poewe,et al. Early distinction of Parkinson‐variant multiple system atrophy from Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.
[40] M. Meade,et al. A guide for the design and conduct of self-administered surveys of clinicians , 2008, Canadian Medical Association Journal.
[41] K. Druschky,et al. Differentiation of Parkinson’s disease and multiple system atrophy in early disease stages by means of I-123-MIBG–SPECT , 2000, Journal of the Neurological Sciences.
[42] Jeremy D. Schmahmann,et al. The Diagnosis and Natural History of Multiple System Atrophy, Cerebellar Type , 2016, Cerebellum.
[43] O. Rascol,et al. MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophy , 2018, Movement disorders : official journal of the Movement Disorder Society.
[44] D. Margouleff,et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease , 1993, Annals of neurology.
[45] P. Sandroni,et al. Blood pressure recovery from Valsalva maneuver in patients with autonomic failure , 2005, Neurology.
[46] D. Dickson,et al. When DLB, PD, and PSP masquerade as MSA , 2015, Neurology.
[47] P. Cortelli,et al. Early stridor onset and stridor treatment predict survival in 136 patients with MSA , 2016, Neurology.
[48] K. Xia,et al. Prediction of orthostatic hypotension in multiple system atrophy and Parkinson disease , 2016, Scientific Reports.
[49] Günther Deuschl,et al. Red flags for multiple system atrophy , 2008, Movement disorders : official journal of the Movement Disorder Society.
[50] S. Jeong,et al. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy , 2017, Neurourology and urodynamics.
[51] Sonja W. Scholz,et al. A critique of the second consensus criteria for multiple system atrophy , 2019, Movement disorders : official journal of the Movement Disorder Society.
[52] R. Freeman,et al. Natural history of pure autonomic failure: A United States prospective cohort , 2017, Annals of neurology.
[53] W. Poewe,et al. New insights into orthostatic hypotension in multiple system atrophy: a European multicentre cohort study , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[54] Han-Joon Kim,et al. Should genetic testing for SCAs be included in the diagnostic workup for MSA? , 2014, Neurology.
[55] W. Meissner,et al. Laboratory‐Supported Multiple System Atrophy beyond Autonomic Function Testing and Imaging: A Systematic Review by the MoDiMSA Study Group , 2021, Movement disorders clinical practice.
[56] M. Moscovich,et al. Differential diagnosis of sporadic adult-onset ataxia: The role of REM sleep behavior disorder. , 2015, Parkinsonism & related disorders.
[57] G. Wenning,et al. Multiple-system atrophy. , 2015, The New England journal of medicine.
[58] R. Freeman,et al. Do we need to evaluate diastolic blood pressure in patients with suspected orthostatic hypotension? , 2017, Clinical Autonomic Research.
[59] E. Benarroch,et al. Pure autonomic failure , 2017, Neurology.
[60] P Sandroni,et al. Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.
[61] K. Kirchhof,et al. Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study , 2003, International Journal of Impotence Research.
[62] J. Jankovic,et al. Natural History of Multiple System Atrophy in North America: A Prospective Cohort Study , 2015, The Lancet Neurology.
[63] Günther Deuschl,et al. The natural history of multiple system atrophy: a prospective European cohort study , 2013, The Lancet Neurology.
[64] K. Iwanaga,et al. Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[65] Nocturnal decrease in vasopressin secretion into plasma in patients with multiple system atrophy , 1999, Journal of neurology, neurosurgery, and psychiatry.
[66] Werner Poewe,et al. Progression of falls in postmortem‐confirmed Parkinsonian disorders , 1999, Movement disorders : official journal of the Movement Disorder Society.
[67] J. Trojanowski,et al. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy , 2007, Neuropathology and applied neurobiology.
[68] G. Plazzi,et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies , 2020, Acta Neuropathologica.
[69] W. Poewe,et al. Urinary retention discriminates multiple system atrophy from Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.
[70] W. Poewe,et al. Diagnostic potential of automated subcortical volume segmentation in atypical parkinsonism , 2016, Neurology.
[71] N. Quinn,et al. Is sphincter electromyography a helpful investigation in the diagnosis of multiple system atrophy? A retrospective study with pathological diagnosis , 2005, Movement disorders : official journal of the Movement Disorder Society.
[72] M. Skalej,et al. Pontine MRI hyperintensities (“the cross sign”) are not pathognomonic for multiple system atrophy (MSA) , 2001, Movement disorders : official journal of the Movement Disorder Society.
[73] Anna Barnes,et al. FDG PET in the differential diagnosis of parkinsonian disorders , 2005, NeuroImage.
[74] W. Oertel,et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: A multicenter study , 2015, Annals of neurology.
[75] R. Freeman,et al. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies , 2018, Annals of neurology.
[76] K. Seppi,et al. Validation of the neurogenic orthostatic hypotension ratio with active standing. , 2020, Annals of Neurology.
[77] Nick C Fox,et al. Conventional magnetic resonance imaging in confirmed progressive supranuclear palsy and multiple system atrophy , 2012, Movement disorders : official journal of the Movement Disorder Society.